Thermo Fisher Scientific Inc. (TN8.DE)
EUR 373.5
(-0.63%)
EUR 373.5
(-0.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 47 Billion USD | -5.09% |
| 2022 | 49.52 Billion USD | 3.97% |
| 2021 | 47.63 Billion USD | 68.77% |
| 2020 | 28.22 Billion USD | 10.37% |
| 2019 | 25.57 Billion EUR | 2.05% |
| 2018 | 25.05 Billion EUR | -3.73% |
| 2017 | 26.02 Billion EUR | 12.66% |
| 2016 | 23.1 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 50.96 Billion EUR | -0.99% |
| 2024 Q1 | 47.7 Billion USD | -0.79% |
| 2023 FY | 47 Billion USD | -5.09% |
| 2023 Q4 | 47 Billion USD | -3.69% |
| 2023 Q3 | 48.8 Billion USD | 6.07% |
| 2023 Q2 | 46.01 Billion USD | -4.51% |
| 2023 Q1 | 48.18 Billion USD | -2.71% |
| 2022 Q4 | 49.52 Billion EUR | 3.69% |
| 2022 Q3 | 47.76 Billion EUR | 4.05% |
| 2022 Q2 | 45.9 Billion EUR | -1.59% |
| 2022 Q1 | 46.64 Billion EUR | -2.08% |
| 2021 Q4 | 47.63 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| NanoRepro AG | 1.08 Million EUR | -4344223.415% |